These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2126464)

  • 41. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.
    Bock SC; Marrinan JA; Radziejewska E
    Biochemistry; 1988 Aug; 27(16):6171-8. PubMed ID: 3191114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amino acid sequence of porcine antithrombin III.
    Tokunaga F; Goto T; Wakabayashi S; Koide T
    J Biochem; 1994 Nov; 116(5):1164-70. PubMed ID: 7896748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin.
    Whisstock JC; Skinner R; Carrell RW; Lesk AM
    J Mol Biol; 2000 Jan; 295(3):651-65. PubMed ID: 10623554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Engineering thermostability in serine protease inhibitors.
    Im H; Ryu MJ; Yu MH
    Protein Eng Des Sel; 2004 Apr; 17(4):325-31. PubMed ID: 15126675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigating changes in the gas-phase conformation of Antithrombin III upon binding of Arixtra using traveling wave ion mobility spectrometry (TWIMS).
    Zhao Y; Singh A; Li L; Linhardt RJ; Xu Y; Liu J; Woods RJ; Amster IJ
    Analyst; 2015 Oct; 140(20):6980-9. PubMed ID: 26115461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A mechanism for heparin-induced potentiation of antithrombin III.
    van Boeckel CA; Grootenhuis PD; Visser A
    Nat Struct Biol; 1994 Jul; 1(7):423-5. PubMed ID: 7664058
    [No Abstract]   [Full Text] [Related]  

  • 51. Crystallography of serpins and serpin complexes.
    Dunstone MA; Whisstock JC
    Methods Enzymol; 2011; 501():63-87. PubMed ID: 22078531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.
    Owen MC; Brennan SO; Lewis JH; Carrell RW
    N Engl J Med; 1983 Sep; 309(12):694-8. PubMed ID: 6604220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Active site of alpha 1-antitrypsin: homologous site in antithrombin-III.
    Carrell RW; Boswell DR; Brennan SO; Owen MC
    Biochem Biophys Res Commun; 1980 Mar; 93(2):399-402. PubMed ID: 6966929
    [No Abstract]   [Full Text] [Related]  

  • 55. Trehalose: is it a potential inhibitor of antithrombin polymerization?
    Martínez-Martínez I
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31147454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the inhibition of thrombin by three plasma protease inhibitors.
    Downing MR; Bloom JW; Mann KG
    Biochemistry; 1978 Jun; 17(13):2649-53. PubMed ID: 79421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural comparisons of the native and reactive-centre-cleaved forms of alpha 1-antitrypsin by neutron- and X-ray-scattering in solution.
    Smith KF; Harrison RA; Perkins SJ
    Biochem J; 1990 Apr; 267(1):203-12. PubMed ID: 2327980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain.
    Tóth L; Fekete A; Balogh G; Bereczky Z; Komáromi I
    J Biomol Struct Dyn; 2015 Sep; 33(9):2023-36. PubMed ID: 25483839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular basis of residue 192 participation in determination of coagulation protease specificity.
    Rezaie AR; Esmon CT
    Eur J Biochem; 1996 Dec; 242(3):477-84. PubMed ID: 9022671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III.
    Sun XJ; Chang JY
    Biochemistry; 1990 Sep; 29(38):8957-62. PubMed ID: 2271571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.